Article
Applied Clinical Trials
New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline
JACKSON, MS, December 10, 2007-The Pharmaceutical Research and Manufacturers of America (PhRMA) delivered a new report on medicines in the research pipeline for major diseases affecting African Americans to Mississippi Governor Haley Barbour today. The report found that America’s pharmaceutical research companies are now testing 691 new medicines to help treat diseases that disproportionately affect African Americans or diseases that are among the top 10 causes of death among African Americans. According to the U.S. Census Bureau, Mississippi has the largest (37 percent) African American population in the United States.
To read the report on the PhRMA Web site, click on the following link: www.phrma.org.
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.